Foreign Investment Companies Turning to Korean Pharmaceutical Companies

Published: 2001-09-28 07:00:00

Updated: 2001-09-28 07:00:00

The reported plans of a number of foreign companies to invest in Korean pharmaceutical companies are expected to make the stock prices of the pharmaceutical companies more flexible.

According to some industry officials, investment firms from Hong Kong, United States, and other countries will ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK